DanielYoungLeeMD

PubMed

• Design and synthesis of a mitochondria-targeting carrier for small molecule drugs.
  Han, J.,Lee, T. H.,Tung, C. H.,Lee, D. Y.> ;Org. Biomol. Chem.. 2014 Nov 08
• Positron Emitting Magnetic Nanoconstructs for PET/MR Imaging.
  Aryal, S.,Key, J.,Stigliano, C.,Landis, M. D.,Lee, D. Y.,Decuzzi, P.> ;Small. 2014 Mar 19
• A Tyrosine Kinase Inhibitor-Based High-Affinity PET Radiopharmaceutical Targets Vascular Endothelial Growth Factor Receptor.
  Li, F.,Jiang, S.,Zu, Y.,Lee, D. Y.,Li, Z.> ;J. Nucl. Med.. 2014 Jun 28
• Systemic Inflammatory Response Syndrome (SIRS) After Administration of Unmodified T-lymphocytes.
  Papadopoulou, A.,Krance, R. A.,Allen, C. E.,Lee, D.,Rooney, C. M.,Brenner, M. K.,Leen, A. M.,Heslop, H. E.> ;Mol. Ther.. 2014 Mar 22
• Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64.
  Bhatnagar, P.,Li, Z.,Choi, Y.,Guo, J.,Li, F.,Lee, D. Y.,Figliola, M.,Huls, H.,Lee, D. A.,Zal, T.,Li, K. C.,Cooper, L. J.> ;Integr Biol (Camb). 2013 Jan
• Molecular theranostics: a primer for the imaging professional.
  Lee, D.Y., Li, K.P.> ;AJR Am J Roentgenol. 2011 Aug
• The roles of microRNAs in tumorigenesis and angiogenesis.
  Yang, W., Lee, D.Y., Ben-David, Y.> ;Int J Physiol Pathophysiol Pharmacol. 2011
• Computer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging.
  Gao, X., Xue, Z., Xing, J., Lee, D.Y., Gottschalk, S.M., Heslop, H.E., Bollard, C.M., Wong, S.C.> ;Acad Radiol. 2010 Apr
• Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging.
  Li, F., Liu, J., Jas, G.S., Zhang, J., Qin, G., Xing, J., Cotes, C., Zhao, H., Wang, X., Diaz, L.A., Shi, Z., Lee, D.Y., Li, K.P., Li, Z.> ;Bioconjug Chem. 2010 Feb 17
• Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration.
  Adkison, K.K., Vaidya, S.S., Lee, D.Y., Koo, S.H., Li, L., Mehta, A.A., Gross, A.S., Polli, J.W., Humphreys, J.E., Lou, Y., Lee, E.D.> ;J Pharm Sci. 2010-02-01
• Expression of versican 3'-untranslated region modulates endogenous microRNA functions.
  Lee, D.Y., Jeyapalan, Z., Fang, L., Yang, J., Zhang, Y., Yee, A.Y., Li, M., Du, W.W., Shatseva, T., Yang, B.B.> ;PLoS One. 2010
• Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.
  Du, W.W., Yang, B.B., Shatseva, T.A., Yang, B.L., Deng, Z., Shan, S.W., Lee, D.Y., Seth, A., Yee, A.J.> ;PLoS One. 2010
• Systems diagnostics: the systems approach to molecular imaging.
  Lee, D.Y., Li, K.P.> ;AJR Am J Roentgenol. 2009-08-01
• A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions.
  Lee, D.Y., Shatseva, T., Jeyapalan, Z., Du, W.W., Deng, Z., Yang, B.B.> ;PLoS One. 2009-01-01
• MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.
  Kahai, S., Lee, S., Lee, D.Y., Yang, J., Li, M., Wang, C., Jiang, Z., Zhang, Y., Peng, C., Yang, B.B.> ;PLoS One. 2009-01-01
• Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.
  Xu, G., Bernaudo, S., Fu, G., Lee, D.Y., Yang, B.B., Peng, C.> ;Mol Biol Cell. 2008 Nov
• MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression.
  Wang, C., Lee, D.Y., Deng, Z., Jeyapalan, Z., Lee, S., Kahai, S., Lu, W., Zhang, Y., Yang, B.B.> ;PLoS One. 2008
• MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.
  Lee, D.Y., Deng, Z., Wang, C., Yang, B.B.> ;Proc Natl Acad Sci U S A. 2007 Dec 18
• The ability of versican to simultaneously cause apoptotic resistance and sensitivity.
  LaPierre, D.P., Lee, D.Y., Li, S., Xie, Y., Zhong, L., Sheng, W., Deng, Z., Yang, B.B.> ;Cancer Res. 2007 May 15
• Versican modulates gap junction intercellular communication.
  Sheng, W., Dong, H., Lee, D.Y., Lu, W., Yang, B.B.> ;J Cell Physiol. 2007 Apr
• Versican mediates mesenchymal-epithelial transition.
  Sheng, W., Wang, G., La Pierre, D.P., Wen, J., Deng, Z., Wong, C.A., Lee, D.Y., Yang, B.B.> ;Mol Biol Cell. 2006 Apr
• Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1.
  Zheng, P., Reis, M., Sparling, C., Lee, D.Y., La Pierre, D.P., Wong, C.A., Deng, Z., Kahai, S., Wen, J., Yang, B.B.> ;J Biol Chem. 2006 Mar 24
• A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
  Li, L., Wartchow, C.A., Danthi, S.N., Shen, Z., Dechene, N., Pease, J., Choi, H.S., Doede, T., Chu, P., Ning, S., Lee, D.Y., Bednarski, M.D., Knox, S.J.> ;Int J Radiat Oncol Biol Phys. 2004 Mar 15
• Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent ind...
  Horowitz, J.C., Lee, D.Y., Waghray, M., Keshamouni, V.G., Thomas, P.E., Zhang, H., Cui, Z., Thannickal, V.J.> ;J Biol Chem. 2004 Jan 9
• Functional genomics guided with MR imaging: mouse tumor model study.
  Guccione, S., Yang, Y., Shi, G., Lee, D.Y., Li, K.P., Bednarski, M.D.> ;Radiology. 2003 Aug
• Join now to see all